Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Cardiovasc Drugs Ther. 2011 Dec;25(6):517–522. doi: 10.1007/s10557-011-6321-9

Table 1.

HEMODYNAMIC VALUES

Heart Rate (beats/min) CON 30-min OCC 3-H REP
 Control 155±5 152±4 154±4
 RPCT 153±6 156±5 157±4
 HOE 140 154±6 157±4 158±5
 HOE + RPCT 158±6 156±5 162±5
 14,15-EEZE 155±4 152±4 152±4
 14,15-EEZE + RPCT 152±3 153±4 152±4
 MS-PPOH 155±6 156±5 154±5
 MS-PPOH + RPCT 153±4 153±2 152±2
Mean Arterial Pressure(mmHg) CON 30-min OCC 3-H REP
 Control 112±5 118±3 113±4
 RPCT 99±6 102±5 104±2
 HOE 140 97±7 92±6 98±5
 HOE + RPCT 96±6 97±8 101±7
 14,14-EEZE 108±5 98±8 99±6
 14,15-EEZE + RPCT 112±8 104±4 112±4
 MS-PPOH 122±5 110±7 111±3
 MS-PPOH + RPCT 117±2 121±8 122±4

All values are the mean ± SEM.( N=8/group). There were no significant differences between groups by ANOVA followed by the Newman-Kuels posthoc test.

Abbreviations: CON = Control

OCC = Occlusion

REP = Reperfusion